This is excellent news. Finally starting to see some momentum now.
Hungary makes sense; given that this trial is treating NSCLC along with prostate and breast cancers, Hungary has the highest incidence of lung cancer in the world (by a large margin):
https://www.wcrf.org/cancer-trends/lung-cancer-statistics/
I guess they must have a lot of smokers in Hungary.
Ann: DARRT-2 Trial Safety Milestone and European Site Activated, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 11.0¢ | $4.623K | 42.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 154392 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 109573 | 3 |
View Market Depth
| Last trade - 15.45pm 08/08/2025 (20 minute delay) ? |
| NOX (ASX) Chart |